205 results

scale2
Access Value

Posted on 01.06.2010

The real worth of medical technologies

The blogosphere has been driven into a foment over the last week or so by a paper by Groeneveld et al entitled ‘Increasing Use of Cardiovascular Devices and Rising Health Costs’. Its conclusions are interesting but, I suggest, not conclusive of anything which should prompt policy makers to ask further questions. Discounted for inflation the […]

By John Wilkinson Former Chief Executive of Eucomed

global-harmony
Global Regulation

Posted on 11.12.2009

An opportunity for true global harmonisation?

In an ideal world we would have the same rules on devices in each country.  As patients, as we live or travel in different countries, we can be confident that should we fall ill, the devices used to help us are as safe as the ones at home.  As businesses, we would be confident that […]

By John Brennan Director Regulations and Industrial Policy

bridge building
Access Regulation

Posted on 06.10.2009

John Brennan: Irish YES to Europe

I put it down to Irish politeness to always say “no” first when asked if we want something and to follow up with a “yes” when asked the second time. “Will you have a cup of Lisbon tea?Oh no thank you, I’ve had quite enough already.Are you sure? I’ve just made some and I can […]

By John Brennan Director Regulations and Industrial Policy

facts-figures
Value

Posted on 18.08.2009

Facts and figures, not political rhetoric, as a basis for healthcare reform

Returning to the daily routine after a long, and hot, summer break is always characterised by mixed feelings. Part wishes the languorous morning routines to carry on whilst other forces bring a refreshed mind optimistic about the challenges ahead. This morning’s bright and early start in Brussels was illuminated by two articles in the Financial […]

By John Wilkinson Former Chief Executive of Eucomed

bank
Business

Posted on 22.07.2009

Credit default swaps and the real world

The arcane world of credit default swaps may seem a very curious subject to stimulate the mind of a life-long medical technology man. My thoughts turned to these strange and questionable instruments, which appear to be one of the roots of the financial crisis, during a week when they were seldom far from the front […]

By John Wilkinson Former Chief Executive of Eucomed

problemorsolution
Value

Posted on 16.07.2009

Are we the problem or the solution?

Browsing the news pages of the web I came across an article in a journal that I am not familiar with from the USA, the grandly titled U.S. News & World Report. The report headed off on a familiar and now even more fashionable track of squarely identifying our industry as the villains of the […]

By John Wilkinson Former Chief Executive of Eucomed

develop-tree
Global

Posted on 08.07.2009

Creating a coordinated global platform to safeguard health development systems in the future

Talking about the role of the EU in the developing world EC Director General for Development Stefano Manservisi described the new approach to health development policy on a global level: “From donorship to partnership”. He explained that access to medicine needs to be viewed as not only provision of medicines but rather the ability to […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed

copenhagen
Value

Posted on 16.06.2009

Treating Osteoarthritis: will new research lead to a “run” of success?

On Thursday 11 June, I attended, as part of the EULAR conference in Copenhagen – Europe’s largest conference on Rheumatology – the session “Structure modification in osteoarthritis: Time to update the guidelines”. What became really apparent was that rheumatologists from Europe and North-America are seriously concerned about the exponentially increasing prevalence and incidence of osteoarthritis […]

By Rosanna Tarricone Director Master of International Health Care Management, Economics and Policy

hc-inno
Business

Posted on 29.05.2009

2009 Hauptstadtkongress debates affordability of innovation for the German healthcare system

Is innovation still affordable with increasingly strained healthcare budgets? How can medical innovations continued to be financed? Panelist of the round table of distinguished speakers Member of the European Parliament Jorgo Chatzimarkakis made a statement which nicely complements the study released by AdvaMed only 2 days ago. He said that innovation does not increase costs […]

By Mark Grossien Former Director Communications & External Affairs at Eucomed